查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853661

心臟疾病影像設備市場：按技術、最終用戶和應用分類 - 全球預測（2025-2032 年）

Coronary Heart Disease Diagnostic Imaging Devices Market by Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟疾病影像市場規模將達到 55.2 億美元，複合年成長率為 9.98%。

關鍵市場統計數據
基準年 2024 25.8億美元
預計年份：2025年 28.4億美元
預測年份 2032 55.2億美元
複合年成長率 (%) 9.98%

心臟疾病影像學的綜合觀點著重於技術、臨床工作流程和數據主導決策的整合。

心臟疾病的診斷越來越依賴一系列先進的影像技術，這些技術共同建構的臨床影像比任何單一技術單獨提供的都更加豐富、細緻。過去十年，影像技術已從解剖結構的簡介式成像轉變為整合結構、功能和分子資訊的綜合評估，從而指導精準治療。因此，臨床醫生、醫院系統和技術供應商如今所處的環境，決定著設備互通性、影像分析和工作流程整合的成敗，而這些因素共同決定臨床療效和商業性可行性。

臨床實踐面臨著在最大限度降低患者風險和簡化治療流程的同時，提供更快、更準確的診斷的壓力。技術進步、日益嚴格的監管以及不斷變化的報銷機制，都在共同推動那些能夠加快診斷速度、減少不必要的侵入性手術並實現長期疾病管理的解決方案獲得認可。本引言為執行摘要摘要的其餘部分奠定了基礎，強調市場成功將取決於那些能夠將技術創新與臨床效用、工作流程最佳化和數據主導的決策支援相結合的企業。

因此，相關人員不僅需要了解各個影像處理平台的功能，還需要了解它們如何在複雜的醫療生態系統中發揮作用。從可改善床邊照護現場的床邊超音波到為介入治療方案製定提供資訊的高解析度電腦斷層超音波，每種影像技術都對連續性醫療服務做出貢獻。以下章節將綜合分析轉型趨勢、貿易政策影響、市場區隔差異、區域差異、企業策略以及實用建議，旨在為心臟疾病影像領域的領先地位指明方向。

人工智慧、混合成像、安全最佳化和基於價值的採購等領域的進步，正在從根本上重塑診斷路徑和供應商競爭格局。

心臟疾病影像學領域再形成，這些因素正在改變臨床醫生檢測、量化和監測疾病的方式。人工智慧和先進的影像分析技術正從先導計畫走向臨床工作流程，實現斑塊自動表徵、灌注定量和分診優先排序，從而縮短解讀時間並提高結果的可重複性。同時，結合解剖和功能資訊的混合和多模態成像策略，例如CT衍生的血流儲備分數和PET/CT聯合通訊協定，正在提高診斷的準確性並減少對侵入性血管造影術的依賴。

另一個重要的轉變是追求降低輻射劑量和保障病人安全。重建演算法、檢測器設計和造影劑使用方面的創新，使得在顯著降低輻射和造影用量的情況下獲得高保真影像成為可能，從而擴大了先進成像技術在體弱或併發症疾病患者中的應用範圍。同時，床邊快速成像和小型化系統的出現，特別是在超音波和低場磁振造影領域，正在使診斷分散化，並支持在門診和急診環境中快速做出決策。

在營運層面，支付者和醫療系統正在加速採用以價值為導向的採購模式，優先考慮療效、效率和總醫療成本。這促使供應商提供配套服務協議、績效保證和雲端訂閱服務。此外，隨著供應商要求自身俱備應對地緣政治動盪和成本波動的能力，全球供應鏈最佳化和本地化生產已成為戰略要務。這些轉變共同拓展了臨床能力，同時也加劇了對整合性、擴充性和可驗證的臨床價值的競爭。

評估關稅驅動的採購壓力、供應鏈重組和成本轉嫁動態如何影響設備設計、分銷和臨床應用。

美國在這​​一年實施的關稅政策對診斷影像技術的採購、製造策略和經濟效益產生了連鎖反應。由於關稅導致進口零件成本上升，製造商不得不重新評估其全球籌資策略，加快供應商多元化，並在許多情況下尋求關鍵子組件的近岸外包或國內生產。這些供應鏈調整改變了前置作業時間、資金配置以及不同影像處理平台的相對成本競爭力。

隨著某些進口設備和組件的採購成本增加，醫療服務提供者和綜合護理網路更加關注整體擁有成本，傾向於選擇那些承諾長期可維護性、遠距離診斷和模組化升級路徑的系統。同時，一些供應商為了維護其市場地位而自行承擔了關稅相關成本，而另一些供應商則將增加的成本轉嫁給了買家，從而在醫院、診斷中心和門診機構之間造成了價格差異。

關稅也影響了創新路徑。預算限制和採購的不確定性促使原始設備製造商 (OEM) 減少對高關稅零件的依賴，轉而採用強調軟體主導差異化的平台設計。與監管機構的關係也發生了變化，在資金週期受限的情況下，企業優先考慮能夠快速產生高價值臨床回報的設備和改進方案。最後，貿易政策鼓勵製造商與區域經銷商建立策略夥伴關係，以減少海關手續的複雜性並建立更可預測的合約安排。綜上所述，這些影響揭示了貿易政策如何透過促進供應鏈韌性、設計模組化和商業靈活性來加速各行業的結構性變革。

透過詳細的細分分析，將設備架構、臨床應用案例和護理環境要求連結起來，從而揭示精準的採用促進因素和技術契合度。

細緻的細分框架揭示了臨床需求、技術能力和購買行為之間的交集，從而影響產品策略和市場推廣計劃。按技術分類，該領域包括電腦斷層掃描（CT）、磁振造影）、光學顯像模式、正子斷層掃描（PET）、單光子發射斷層掃描（SPECT）和超音波。特別是CT，其架構各不相同，例如雙源CT、多切面CT和單切片電腦斷層掃描器 ，每種架構在時間解析度、空間解析度和吞吐量之間各有優劣。 MRI則根據磁場強度進一步細分：5特斯拉、3特斯拉和>3特斯拉/點，這會影響訊號雜訊比、採集速度以及對高階組織表徵通訊協定的適用性。磁振造影成像技術包括冠狀動脈內成像方式，例如血管內光學相干斷層掃描（IVOCT）和近紅外線光譜（NIR），這些技術可以評估斑塊的微觀結構和成分，是對大血管成像的補充。超音波診斷設備種類繁多，包括 2D 平台、 3D容積成像和用於量化血流動力學的多普勒功能。

從終端使用者的觀點來看，門診醫療中心、診斷中心、醫院和專科診所的採用模式各不相同，每種環境優先考慮的方面也不同，例如資本密集度、吞吐量和臨床靈活性。診斷目標分為解剖學評估、灌注成像和活性成像，而灌注通訊協定本身又分為靜止灌注和負荷灌注模式，每種模式對硬體和軟體的要求都不同。了解這些細分領域有助於臨床醫生和採購團隊權衡各種利弊，例如速度與準確性、便攜性與全面功能以及資本投資與單次掃描成本。因此，供應商和醫療系統可以透過將產品功能與特定的臨床工作流程和採購限制相匹配，實現更清晰的差異化並加快產品推廣。

區域醫療保健基礎設施、報銷框架和臨床重點如何推動全球市場中不同的診斷影像應用模式

醫療基礎設施、法規環境和支付模式的差異造就了區域性的動態變化，進而影響創新軌跡和臨床應用的速度。在美洲，對三級醫療機構的高額資本投入以及對微創治療路徑的重視，推動了對先進電腦斷層掃描器）、高場磁振造影（MRI）和混合成像解決方案的需求，這些方案旨在減少不必要的侵入性診斷。隨著醫療服務從學術中心轉移到社區醫院和門診機構，人們對能夠將診斷能力擴展到傳統醫院以外的可攜式、經濟高效的診斷設備也表現出濃厚的興趣。

歐洲、中東和非洲的情況差異很大。西歐成熟的醫療體係正迅速採用劑量降低技術和人工智慧驅動的分析方法，而中東部分地區則優先考慮旗艦三級醫療投資和新興臨床網路。在非洲，醫療服務的可近性和可靠性往往是首要考慮因素，這推動了穩健、低維護成本的系統和遠距影像夥伴關係的普及，從而增強了資源有限的專科醫生的能力。該地區的報銷結構和跨境監管協調對採購週期和供應商策略有顯著影響。

亞太地區依然是一個充滿活力的成長區域，這得益於其龐大的人口基數、不斷成長的中階對先進診斷的需求以及各國對醫療基礎設施的大力投入。區域製造商和國際原始設備製造商（OEM）在服務模式、性價比和區域夥伴關係展開了激烈的競爭。儘管互通性、基於雲端的影像共用和培訓計畫仍然是各地區推廣應用的關鍵，但高階三級醫療投資與分散式診斷服務之間的平衡在不同地區差異顯著，從而形成了各自獨特的商業性模式。

為什麼企業正從以硬體為中心的銷售模式轉向整合軟體、服務和臨床證據的整合平台，以確保與機構建立長期夥伴關係？

冠狀動脈成像領域的企業策略正圍繞著一系列實際需求趨於一致：平台模組化、服務和軟體帶來的持續收入、臨床證據生成以及策略夥伴關係。領先的製造商正在拓展業務範圍，不再局限於硬體，而是提供雲端分析、承包安裝和維護合約以及臨床醫生培訓項目，從而加速實現臨床價值。這種轉變反映出人們逐漸意識到，長期的客戶關係和數據主導的服務往往比一次性的設備銷售更能帶來更高的終身價值。

對於那些尋求快速進入互補技術領域的公司而言，研發、策略合作和有針對性的收購仍然是關鍵途徑，例如專注於斑塊檢測的人工智慧新興企業公司和開發用於量化冠狀動脈灌注的軟體的專業公司。此外，策略投資者優先考慮那些能夠展現清晰的臨床結果、法規核准路徑以及可在各種醫療環境中可擴展部署模式的公司。差異化服務，例如遠端系統健康監測、預測性維護以及將供應商獎勵與醫療服務提供者目標相結合的按績效付費契約，正變得日益重要。

最後，對技術、臨床和監管人才的競爭正在塑造創新管道。那些將臨床領域專業知識與軟體和雲端工程能力結合的機構，更有能力提供滿足多學科心臟團隊需求的整合解決方案。因此，現今的產品藍圖通常體現為硬體改進、模組化軟體升級以及生態系統夥伴關係的結合，旨在顯著提升診斷準確性、工作流程效率和患者體驗。

為供應商和醫療系統提供可操作的策略重點，以平衡創新、供應鏈韌性和基於價值的商業模式，從而加速採用。

為了最大限度地提高應用率和長期價值，行業領導者應採取多管齊下的策略，重點關注臨床結果、營運彈性以及靈活的商業模式。首先，應優先投資於人工智慧驅動的影像分析和工作流程自動化，以顯著縮短閱片時間並降低閱片者之間的差異。其次，應重新設計產品系列，強調模組化設計，使核心平台可以透過軟體和模組化硬體的更換進行升級，而無需進行大規模的資本投入。

第三，我們將透過供應商多元化、尋找替代零件供應商以及評估關鍵製造流程的近岸外包方案，來增強供應鏈的韌性。這些措施將降低我們受關稅波動和物流中斷的影響，同時提高客戶前置作業時間的可預測性。第四，我們將透過擴展包含分析、運作保障和培訓的服務和訂閱產品，創造經常性收入來源，並將供應商獎勵與臨床和營運結果掛鉤。第五，我們將尋求與醫療系統和支付方建立有針對性的夥伴關係，以產生支持基於價值的合約的真實世界證據，並開展合作試點項目，以證明降低侵入性手術率和提高患者吞吐量的有效性。

最後，要根據不同地區和醫療環境調整市場開發方法，因為不同三級醫院、診斷中心、門診診所和專科診所的採購促進因素各不相同。投資於臨床醫師教育、遠距影像網路和區域服務能力將加速專科服務受限市場的普及，而打包服務和療效保證則更能引起重視整體醫療成本的醫療系統的共鳴。

一個嚴謹的混合方法研究框架，結合了臨床醫生訪談、技術文獻綜述、供應鏈圖譜繪製和情境分析，以檢驗策略結論。

本分析整合了多方面的證據，以確保方法的嚴謹性和實際應用價值。主要研究包括對臨床醫生、採購負責人和設備工程師進行結構化訪談，以了解臨床需求、採購限制和技術偏好等第一線情況。此外，專家諮詢小組也參與了訪談，檢驗了人工智慧整合、混合成像技術應用以及貿易政策變化對營運的影響等新興主題。次要分析則利用了同儕審查文獻、監管申報文件、設備技術規範和已發布的臨床指南，對不同影像方式的性能特徵和臨床效用進行三角驗證。

為了解商業和供應鏈的影響，本研究採用了定性供應商分析、合約審查摘要以及關稅和物流中斷情境分析。研究還考察了產品藍圖和專利趨勢，以確定技術差異化領域和潛在的競爭切入點。最後，研究結果透過情境規劃研討會進行了壓力測試，模擬了不同報銷和投資環境下的產品採納路徑，為尋求將產品策略與臨床需求和採購實際情況相協調的相關人員提供了明確的指南。

總結性報告強調，必須將臨床檢驗、模組化產品策略和服務主導的商業性模式結合，才能實現長期價值。

摘要：心臟疾病影像生態系統正處於曲折點，技術成熟度、數據分析和採購模式的轉變正在共同重塑臨床路徑。最成功的方案是將高保真影像技術與人工智慧驅動的分析、模組化升級以及使供應商激勵機制與臨床結果一致的服務模式獎勵。貿易政策的波動和區域基礎設施的差異既帶來了風險也帶來了機遇，因此需要供應鏈具備韌性，並制定與區域戰略相符的獎勵。

因此，從設備製造商到醫院高管，相關人員必須優先考慮那些能夠加快診斷速度、降低手術風險並顯著改善患者預後，同時保持營運靈活性的投資。透過專注於模組化平台、循證夥伴關係以及持續的服務收入，各機構可以在日益以互通性和基於價值的採購為驅動力的市場中建立穩固的地位。總而言之，結論顯而易見：臨床檢驗與可擴展的商業模式相結合，將決定誰將引領下一波冠心病診斷創新浪潮。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用人工智慧演算法對冠狀動脈CT血管造影術中的斑塊進行自動評估
  • 透過整合光子計數CT技術，提高了冠狀動脈斑塊的可視化和定量分析能力。
  • FFR-CT非侵入性血流儲備分數的出現，為指導冠狀動脈介入治療決策提供了可能。
  • 低劑量心臟CT通訊協定的進展可最大限度地減少常規冠狀動脈篩檢期間的輻射暴露
  • 改良床邊手持式超音波設備以進行冠狀動脈血流儲備評估
  • 利用PET/MRI混合系統，結合冠狀動脈發炎的解剖影像和分子影像。
  • 開發靶向易損動脈粥樣硬化斑塊斑塊標記的新型分子PET示蹤劑
  • 雲端基礎平台的遠端心臟影像分析和遠距心臟病學協作的實施
  • 將3D列印技術應用於患者特異性冠狀動脈模型術前規劃
  • 基於深度學習的工作流程自動化，可高效產生心臟影像報告

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按技術分類的心臟疾病成像設備市場

  • CT
    • 雙源CT
    • 多切面CT
    • 單切片電腦斷層掃描器
  • MRI
    • 1.5T
    • 3T
    • 3噸或以上
  • 光學成像
    • IVOCT
    • NIRS
  • PET
  • SPECT
  • 超音波
    • 2D
    • 3D
    • 多普勒

9. 依最終用戶分類的心臟疾病影像設備市場

  • 門診治療中心
  • 診斷中心
  • 醫院
  • 專科診所

第10章：心臟疾病影像設備市場（依應用領域分類）

  • 解剖學評估
  • 灌注影像
    • 靜止狀態下的灌注
    • 壓力灌注
  • 活性成像

第11章心臟疾病影像設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章心臟疾病診斷設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

13. 各國心臟疾病影像設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Carestream Health, Inc.
    • Agfa-Gevaert NV
    • Esaote SpA
Product Code: MRR-8C74ADFC03A3

The Coronary Heart Disease Diagnostic Imaging Devices Market is projected to grow by USD 5.52 billion at a CAGR of 9.98% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.58 billion
Estimated Year [2025] USD 2.84 billion
Forecast Year [2032] USD 5.52 billion
CAGR (%) 9.98%

An integrative perspective on coronary heart disease diagnostic imaging that highlights the convergence of technology, clinical workflows, and data-driven decision making

The diagnosis of coronary heart disease increasingly relies on an array of advanced imaging modalities that together create a richer, more nuanced clinical picture than any single technique could provide alone. Over the last decade, imaging has shifted from standalone anatomical snapshots to integrated assessments that combine structural, functional, and molecular information to guide precision care. As a result, clinicians, hospital systems, and technology vendors now operate in an environment where device interoperability, image analytics, and workflow integration determine both clinical impact and commercial viability.

In clinical practice, the imperative is clear: deliver faster, more accurate diagnosis while minimizing patient risk and streamlining care pathways. Technological advances, regulatory rigor, and evolving reimbursement practices are converging to reward solutions that shorten time to diagnosis, reduce unnecessary invasive procedures, and enable longitudinal disease management. This introduction frames the remainder of the executive summary by emphasizing that successful market actors will be those who align engineering innovation with clinical utility, workflow optimization, and data-driven decision support.

Consequently, stakeholders must understand not only the capabilities of individual imaging platforms but also how they function within complex care ecosystems. From point-of-care ultrasound that improves bedside triage to high-resolution computed tomography that informs interventional planning, each modality contributes to a continuum of care. The subsequent sections synthesize transformative trends, trade policy impacts, segmentation nuances, regional variations, corporate strategies, and practical recommendations that together chart a pathway for leaders in coronary heart disease diagnostic imaging.

How advances in artificial intelligence, hybrid imaging, safety optimization, and value-based procurement are fundamentally reshaping diagnostic pathways and vendor competition

The landscape of coronary heart disease diagnostic imaging is being reshaped by several convergent forces that are transforming how clinicians detect, quantify, and monitor disease. Artificial intelligence and advanced image analytics have moved from pilot projects into clinical workflows, enabling automated plaque characterization, perfusion quantification, and triage prioritization that reduce interpretation time and enhance reproducibility. Simultaneously, hybrid and multimodal imaging strategies that pair anatomical and functional information-such as computed tomography-derived fractional flow reserve and combined PET/CT protocols-are increasing diagnostic confidence and reducing the reliance on invasive angiography.

Another pivotal shift is the relentless drive toward dose reduction and patient safety. Innovations in reconstruction algorithms, detector design, and contrast usage are allowing for high-fidelity images at markedly lower radiation and contrast loads, which broadens the suitability of advanced imaging for frail and comorbid populations. At the same time, the emergence of point-of-care and compact systems, particularly in ultrasound and lower-field MR, is decentralizing diagnostics and enabling faster decision-making in ambulatory and emergency settings.

Operationally, payers and health systems are accelerating adoption of value-based procurement models that prioritize outcomes, throughput, and total cost of care. This is prompting vendors to offer bundled service contracts, performance guarantees, and cloud-enabled subscription services. Finally, global supply chain optimization and localized manufacturing are becoming strategic imperatives as vendors seek resilience against geopolitical disruption and cost volatility. In combination, these shifts are expanding clinical capability while intensifying competition around integration, scalability, and demonstrable clinical value.

Assessing how tariff-driven procurement pressures, supply chain realignments, and cost pass-through dynamics are influencing device design, distribution, and clinical adoption

United States tariff measures implemented in the year in question have had a cascading impact on procurement, manufacturing strategies, and the economics of diagnostic imaging technologies. Tariff-induced cost increases for imported components prompted manufacturers to reassess global sourcing strategies, accelerate supplier diversification, and in many cases explore nearshoring or domestic production for critical subassemblies. These supply chain adaptations have altered lead times, capital allocation, and the relative cost competitiveness of different imaging platforms.

As procurement costs rose for certain imported devices and parts, healthcare providers and integrated delivery networks intensified scrutiny of total cost of ownership, favoring systems that promised long-term serviceability, remote diagnostics, and modular upgrade paths. In parallel, some vendors absorbed tariff-related expenses to protect their market positioning, while others passed incremental costs to purchasers, creating differential pricing pressure across hospitals, diagnostic centers, and ambulatory settings.

Tariffs also influenced innovation pathways. Budgetary constraints and procurement unpredictability pushed OEMs toward platform designs that reduced reliance on tariff-exposed components and emphasized software-driven differentiation. Regulatory interactions shifted as well, with companies prioritizing devices and modifications that offered quick, high-value clinical returns within constrained capital cycles. Finally, trade policy fostered strategic partnerships between manufacturers and regional distributors to mitigate customs complexity and to establish more predictable contractual arrangements. Taken together, these effects underscore that trade measures can accelerate structural change across the industry by catalyzing supply chain resilience, design modularity, and commercial flexibility.

Detailed segmentation analysis linking device architectures, clinical use cases, and care setting requirements to reveal precise adoption drivers and technology fit

A nuanced segmentation framework reveals where clinical demand intersects with technological capability and purchasing behavior, providing clarity for product strategy and go-to-market planning. When examined by technology, the field comprises computed tomography, magnetic resonance imaging, optical imaging modalities, positron emission tomography, single-photon emission computed tomography, and ultrasound. Computed tomography in particular is differentiated by architectures such as dual-source CT, multi-slice CT, and single-slice CT, each offering distinct trade-offs between temporal resolution, spatial resolution, and throughput. Magnetic resonance imaging is further stratified by field strength categories of one point five tesla, three tesla, and above three tesla, which influence signal-to-noise, acquisition speed, and suitability for advanced tissue characterization protocols. Optical imaging techniques include intracoronary modalities such as intravascular optical coherence tomography and near-infrared spectroscopy, which provide microstructural and compositional plaque assessment that complements macrovascular imaging. Ultrasound systems vary across two-dimensional platforms, three-dimensional volumetric imaging, and Doppler capabilities that quantify flow dynamics.

Looking through the lens of end users, adoption patterns diverge across ambulatory care centers, diagnostic centers, hospitals, and specialty clinics, with each setting prioritizing a different mix of capital intensity, throughput, and clinical flexibility. Diagnostic objectives cluster into anatomical assessment, perfusion imaging, and viability imaging, where perfusion protocols themselves bifurcate into resting perfusion and stress perfusion paradigms that drive different hardware and software requirements. Understanding these segments together illuminates the trade-offs clinicians and procurement teams weigh: speed versus precision, portability versus comprehensive capability, and capital expenditure versus per-scan economics. Consequently, vendors and health systems that map product features to specific clinical workflows and procurement constraints will achieve clearer differentiation and higher adoption velocity.

How regional healthcare infrastructure, reimbursement frameworks, and clinical priorities are driving divergent adoption models for diagnostic imaging across global markets

Regional dynamics are shaping both the trajectory of innovation and the pace of clinical uptake, driven by variations in healthcare infrastructure, regulatory environments, and payer models. In the Americas, high levels of capital investment in tertiary centers and a strong emphasis on minimally invasive care pathways are driving demand for advanced computed tomography, high-field magnetic resonance systems, and hybrid imaging solutions that reduce unnecessary invasive diagnostics. Transitioning from academic centers to community hospitals and ambulatory settings, there is also significant interest in portable, cost-effective modalities that can extend diagnostic capability outside traditional hospital walls.

Europe, Middle East & Africa exhibits considerable heterogeneity: established Western European healthcare systems are rapidly adopting dose-reduction technologies and AI-enabled analytics, while parts of the Middle East prioritize flagship tertiary investments and emerging clinical networks. In Africa, the imperative often centers on access and reliability, pushing adoption toward robust, low-maintenance systems and tele-radiology partnerships that can amplify limited specialist capacity. Reimbursement structures and cross-border regulatory harmonization in this region exert a strong influence on procurement cycles and vendor strategies.

Asia-Pacific continues to be a dynamic growth arena, propelled by large population bases, expanding middle-class demand for advanced diagnostics, and national investments in healthcare infrastructure. Regional manufacturers and international OEMs compete aggressively on service models, price-performance ratios, and local partnerships. Across all regions, interoperability, cloud-enabled image sharing, and training programs remain central to adoption, but the balance between high-end tertiary investments and decentralized diagnostic access varies significantly by geography, shaping distinct commercial approaches.

Why companies are shifting from hardware-centric sales to integrated platforms that combine software, services, and clinical evidence to secure long-term institutional partnerships

Corporate strategies within the coronary diagnostic imaging arena are converging around a set of practical imperatives: platform modularity, recurring revenue through service and software, clinical evidence generation, and strategic partnerships. Leading manufacturers are expanding beyond hardware to offer cloud-enabled analytics, turnkey installation and maintenance contracts, and clinician training programs that accelerate time to clinical value. This shift reflects an understanding that long-term customer relationships and data-driven services often yield higher lifetime value than one-time equipment sales.

Mergers, strategic alliances, and targeted acquisitions continue to be a primary route for companies seeking rapid entry into complementary technologies, such as AI startups focused on plaque detection or specialist firms developing coronary perfusion quantification software. Additionally, strategic investors are placing emphasis on companies that demonstrate clear clinical outcomes, regulatory clearance pathways, and scalable deployment models for varied care settings. Service differentiation increasingly includes remote monitoring of system health, predictive maintenance, and outcome-linked contracting that aligns vendor incentives with institutional goals.

Finally, competition for talent-engineers, clinical specialists, and regulatory experts-is shaping innovation pipelines. Organizations that combine clinical domain expertise with software and cloud engineering capabilities are better positioned to deliver integrated solutions that meet the needs of multi-disciplinary cardiac teams. As a result, product roadmaps now commonly reflect a combination of hardware improvements, modular software upgrades, and ecosystem partnerships aimed at delivering measurable improvements in diagnostic accuracy, workflow efficiency, and patient experience.

Actionable strategic priorities for vendors and health systems that balance innovation, supply chain resilience, and value-based commercial models to accelerate adoption

Industry leaders should adopt a multi-pronged strategy that emphasizes clinical outcomes, operational resilience, and flexible commercial models to maximize adoption and long-term value. First, prioritize investments in AI-driven image analysis and workflow automation that demonstrably reduce interpretation time and inter-reader variability; pilot projects should be designed to capture clinical endpoints and economic benefits to enable reimbursement discussions and procurement approvals. Second, redesign product portfolios to emphasize modularity, enabling core platforms to be upgraded via software or modular hardware swaps rather than full capital replacement, which preserves customer relationships and reduces procurement friction.

Third, strengthen supply chain resilience by diversifying suppliers, qualifying alternative component sources, and evaluating nearshoring options for critical manufacturing steps. These measures will reduce exposure to tariff volatility and logistical disruption while improving lead time predictability for customers. Fourth, expand service and subscription offerings that bundle analytics, uptime guarantees, and training, thereby creating recurring revenue streams and aligning vendor incentives with clinical and operational outcomes. Fifth, pursue targeted partnerships with health systems and payers to generate real-world evidence that supports value-based contracting and to create joint pilots that illustrate reduced invasive procedural rates or improved patient throughput.

Finally, tailor go-to-market approaches by region and care setting, recognizing the different procurement drivers across tertiary hospitals, diagnostic centers, ambulatory care sites, and specialty clinics. Investments in clinician education, tele-radiology networks, and local service capabilities will accelerate adoption in markets with constrained specialist availability, while bundled offerings and outcome guarantees will resonate in systems prioritizing total cost of care.

A rigorous mixed-methods research framework combining clinician interviews, technical dossier review, supply chain mapping, and scenario analysis to validate strategic conclusions

This analysis synthesizes multiple evidence streams to ensure methodological rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, and device engineers to capture frontline insights into clinical requirements, procurement constraints, and technology preferences. These conversations were complemented by expert advisory panels that validated emerging themes such as AI integration, hybrid imaging adoption, and the operational impact of trade policy changes. Secondary analysis drew upon peer-reviewed literature, regulatory filings, device technical specifications, and published clinical guidelines to triangulate performance characteristics and clinical utility across modalities.

To understand commercial and supply chain implications, the research incorporated qualitative supplier mapping, contract review summaries, and scenario analysis of tariff and logistics disruptions. Product roadmaps and patent trends were examined to identify areas of technological differentiation and potential competitive entry points. Finally, findings were stress-tested through scenario planning workshops that modeled adoption pathways across different reimbursement and investment environments, providing robust directional guidance for stakeholders seeking to align product strategy with clinical demand and procurement realities.

Concluding synthesis that underscores the imperative to align clinical validation, modular product strategy, and service-led commercial approaches to capture long-term value

In summary, the diagnostic imaging ecosystem for coronary heart disease is at an inflection point where technological maturity, data analytics, and changing procurement models are collectively redefining clinical pathways. The most successful approaches will integrate high-fidelity imaging modalities with AI-enabled analysis, modular upgradeability, and service models that align vendor incentives with clinical outcomes. Trade policy fluctuations and regional differences in infrastructure create both risk and opportunity, incentivizing supply chain resilience and tailored regional strategies.

Stakeholders-from device manufacturers to hospital executives-must therefore prioritize investments that reduce time to diagnosis, lower procedural risk, and demonstrably improve patient outcomes while maintaining operational flexibility. By focusing on modular platforms, evidence-generation partnerships, and recurrent service revenues, organizations can build defensible positions in a market increasingly driven by interoperability and value-based procurement. The overarching conclusion is clear: combining clinical validation with scalable commercial models will determine who leads the next wave of diagnostic innovation in coronary care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of artificial intelligence algorithms for automated plaque characterization in coronary CT angiography
  • 5.2. Integration of photon-counting computed tomography to improve coronary plaque visualization and quantification
  • 5.3. Emergence of FFR-CT noninvasive fractional flow reserve assessment to guide coronary intervention decisions
  • 5.4. Advancements in low-dose cardiac CT protocols to minimize radiation exposure in routine coronary screening
  • 5.5. Expansion of point-of-care handheld ultrasound devices for bedside coronary flow reserve assessment
  • 5.6. Utilization of hybrid PET/MRI systems for combined anatomical and molecular imaging of coronary inflammation
  • 5.7. Development of novel molecular PET tracers targeting vulnerable atherosclerotic plaque biomarkers
  • 5.8. Implementation of cloud-based platforms for remote cardiac imaging analytics and telecardiology collaboration
  • 5.9. Integration of 3D printing technology for patient-specific coronary artery phantoms in preprocedural planning
  • 5.10. Incorporation of deep learning-driven workflow automation to streamline cardiac imaging report generation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Heart Disease Diagnostic Imaging Devices Market, by Technology

  • 8.1. CT
    • 8.1.1. Dual-Source CT
    • 8.1.2. Multi-Slice CT
    • 8.1.3. Single-Slice CT
  • 8.2. MRI
    • 8.2.1. 1.5T
    • 8.2.2. 3T
    • 8.2.3. Above 3T
  • 8.3. Optical Imaging
    • 8.3.1. IVOCT
    • 8.3.2. NIRS
  • 8.4. PET
  • 8.5. SPECT
  • 8.6. Ultrasound
    • 8.6.1. 2D
    • 8.6.2. 3D
    • 8.6.3. Doppler

9. Coronary Heart Disease Diagnostic Imaging Devices Market, by End User

  • 9.1. Ambulatory Care Centers
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Coronary Heart Disease Diagnostic Imaging Devices Market, by Application

  • 10.1. Anatomical Assessment
  • 10.2. Perfusion Imaging
    • 10.2.1. Resting Perfusion
    • 10.2.2. Stress Perfusion
  • 10.3. Viability Imaging

11. Coronary Heart Disease Diagnostic Imaging Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Coronary Heart Disease Diagnostic Imaging Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Coronary Heart Disease Diagnostic Imaging Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. GE Healthcare
    • 14.3.2. Siemens Healthineers AG
    • 14.3.3. Koninklijke Philips N.V.
    • 14.3.4. Canon Medical Systems Corporation
    • 14.3.5. Fujifilm Holdings Corporation
    • 14.3.6. Hitachi, Ltd.
    • 14.3.7. Shimadzu Corporation
    • 14.3.8. Carestream Health, Inc.
    • 14.3.9. Agfa-Gevaert N.V.
    • 14.3.10. Esaote S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 256. E